Cargando…

Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application

Metastatic dissemination represents a hallmark of cancer that is responsible for the high mortality rate. Recently, emerging evidence demonstrates a time-series event—pre-metastatic niche (PMN) has a profound impact on cancer metastasis. Exosomes, cell-free DNA (cfDNA), circulating tumor cells (CTC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Kong, Ying, Dang, Qin, Weng, Siyuan, Zheng, Youyang, Ren, Yuqing, Lv, Jinxiang, Li, Na, Han, Yilin, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334814/
https://www.ncbi.nlm.nih.gov/pubmed/35911705
http://dx.doi.org/10.3389/fimmu.2022.958360
_version_ 1784759188727005184
author Liu, Zaoqu
Kong, Ying
Dang, Qin
Weng, Siyuan
Zheng, Youyang
Ren, Yuqing
Lv, Jinxiang
Li, Na
Han, Yilin
Han, Xinwei
author_facet Liu, Zaoqu
Kong, Ying
Dang, Qin
Weng, Siyuan
Zheng, Youyang
Ren, Yuqing
Lv, Jinxiang
Li, Na
Han, Yilin
Han, Xinwei
author_sort Liu, Zaoqu
collection PubMed
description Metastatic dissemination represents a hallmark of cancer that is responsible for the high mortality rate. Recently, emerging evidence demonstrates a time-series event—pre-metastatic niche (PMN) has a profound impact on cancer metastasis. Exosomes, cell-free DNA (cfDNA), circulating tumor cells (CTC), and tumor microenvironment components, as critical components in PMN establishment, could be monitored by liquid biopsy. Intensive studies based on the molecular profile of liquid biopsy have made it a viable alternative to tissue biopsy. Meanwhile, the complex molecular mechanism and intercellular interaction are great challenges for applying liquid biopsy in clinical practice. This article reviews the cellular and molecular components involved in the establishment of the PMN and the promotion of metastasis, as well as the mechanisms of their interactions. Better knowledge of the characteristics of the PMN may facilitate the application of liquid biopsy for clinical diagnosis, prognosis, and treatment.
format Online
Article
Text
id pubmed-9334814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93348142022-07-30 Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application Liu, Zaoqu Kong, Ying Dang, Qin Weng, Siyuan Zheng, Youyang Ren, Yuqing Lv, Jinxiang Li, Na Han, Yilin Han, Xinwei Front Immunol Immunology Metastatic dissemination represents a hallmark of cancer that is responsible for the high mortality rate. Recently, emerging evidence demonstrates a time-series event—pre-metastatic niche (PMN) has a profound impact on cancer metastasis. Exosomes, cell-free DNA (cfDNA), circulating tumor cells (CTC), and tumor microenvironment components, as critical components in PMN establishment, could be monitored by liquid biopsy. Intensive studies based on the molecular profile of liquid biopsy have made it a viable alternative to tissue biopsy. Meanwhile, the complex molecular mechanism and intercellular interaction are great challenges for applying liquid biopsy in clinical practice. This article reviews the cellular and molecular components involved in the establishment of the PMN and the promotion of metastasis, as well as the mechanisms of their interactions. Better knowledge of the characteristics of the PMN may facilitate the application of liquid biopsy for clinical diagnosis, prognosis, and treatment. Frontiers Media S.A. 2022-07-15 /pmc/articles/PMC9334814/ /pubmed/35911705 http://dx.doi.org/10.3389/fimmu.2022.958360 Text en Copyright © 2022 Liu, Kong, Dang, Weng, Zheng, Ren, Lv, Li, Han and Han https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Liu, Zaoqu
Kong, Ying
Dang, Qin
Weng, Siyuan
Zheng, Youyang
Ren, Yuqing
Lv, Jinxiang
Li, Na
Han, Yilin
Han, Xinwei
Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
title Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
title_full Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
title_fullStr Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
title_full_unstemmed Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
title_short Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
title_sort liquid biopsy in pre-metastatic niche: from molecular mechanism to clinical application
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334814/
https://www.ncbi.nlm.nih.gov/pubmed/35911705
http://dx.doi.org/10.3389/fimmu.2022.958360
work_keys_str_mv AT liuzaoqu liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT kongying liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT dangqin liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT wengsiyuan liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT zhengyouyang liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT renyuqing liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT lvjinxiang liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT lina liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT hanyilin liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication
AT hanxinwei liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication